Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Targeted combined anti-inflammatory and angiostatic therapy in advanced melanoma: a randomized phase II trial.
Melanoma Res. 2007 Dec;17(6):360-4. doi: 10.1097/CMR.0b013e3282f1d2c8.
Melanoma Res. 2007.
PMID: 17992118
Clinical Trial.
Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors.
Vogt T, Hafner C, Bross K, Bataille F, Jauch KW, Berand A, Landthaler M, Andreesen R, Reichle A.
Vogt T, et al. Among authors: berand a.
Cancer. 2003 Nov 15;98(10):2251-6. doi: 10.1002/cncr.11775.
Cancer. 2003.
PMID: 14601096
Free article.
Clinical Trial.
Item in Clipboard
Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far-advanced melanoma and soft tissue sarcoma.
Reichle A, Bross K, Vogt T, Bataille F, Wild P, Berand A, Krause SW, Andreesen R.
Reichle A, et al. Among authors: berand a.
Cancer. 2004 Nov 15;101(10):2247-56. doi: 10.1002/cncr.20574.
Cancer. 2004.
PMID: 15470711
Free article.
Item in Clipboard
Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma.
Meyer S, Vogt T, Landthaler M, Berand A, Reichle A, Bataille F, Marx AH, Menz A, Hartmann A, Kunz-Schughart LA, Wild PJ.
Meyer S, et al. Among authors: berand a.
PPAR Res. 2009;2009:848645. doi: 10.1155/2010/848645. Epub 2009 Jul 20.
PPAR Res. 2009.
PMID: 19639032
Free PMC article.
Item in Clipboard
Modular therapy approach in metastatic castration-refractory prostate cancer.
Walter B, Rogenhofer S, Vogelhuber M, Berand A, Wieland WF, Andreesen R, Reichle A.
Walter B, et al. Among authors: berand a.
World J Urol. 2010 Dec;28(6):745-50. doi: 10.1007/s00345-010-0567-x. Epub 2010 May 19.
World J Urol. 2010.
PMID: 20490506
Clinical Trial.
Item in Clipboard
Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial.
Walter B, Schrettenbrunner I, Vogelhuber M, Grassinger J, Bross K, Wilke J, Suedhoff T, Berand A, Wieland WF, Rogenhofer S, Andreesen R, Reichle A.
Walter B, et al. Among authors: berand a.
Med Oncol. 2012 Jun;29(2):799-805. doi: 10.1007/s12032-011-9982-0. Epub 2011 May 24.
Med Oncol. 2012.
PMID: 21607771
Clinical Trial.
Item in Clipboard
C-reactive Protein in Patients with Metastatic Clear Cell Renal Carcinoma: An Important Biomarker for Tumor-associated Inflammation.
Reichle A, Grassinger J, Bross K, Wilke J, Suedhoff T, Walter B, Wieland WF, Berand A, Andreesen R.
Reichle A, et al. Among authors: berand a.
Biomark Insights. 2007 Feb 7;1:87-98.
Biomark Insights. 2007.
PMID: 19690640
Free PMC article.
Item in Clipboard
Cite
Cite